(PR-inside.com) http://www.ivaxdiagnostics.com - IVAX Diagnostics, Inc. (AMEX:IVD) announced today that Paul F. Kennedy has been appointed the Company's Chief Executive Officer, President and Chairman of the Board of Directors. Paul F. Kennedy has more than 30 years of senior executive experience with Novo Nordisk France, a French subsidiary of the world's leading pharmaceutical company in the insulin market, Abbott France, a French subsidiary of the multinational pharmaceutical company, and Boots Co. Ltd., a U.K.-based healthcare retailer. During his 15-year tenure as Chief Executive Officer and President of Novo Nordisk France, that company achieved a market share of more than 65% of ..
More...
More...